eliglustat and its Impurities

Eliglustat is a glucosylceramide synthase inhibitor indicated for the long-term treatment of type 1 Gaucher disease. Eliglustat, marketed by Genzyme as CERDELGA.. Reference standards of Eliglustat API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

Displaying 41 results for eliglustat Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 05 92000

Eliglustat

Eliglustat


  • Catalogue No.:PA 05 92000

  • CAS :

    491833-29-5

  • Molecular Formula : C23H36N2O4

  • Molecular Weight : 404.54

Drug Reference Standards & Impurity Synthesis in India
PA STI 036881

Eliglustat-d4

Eliglustat-d4


  • Catalogue No.:PA STI 036881

  • CAS :

    1628700-81-1

  • Molecular Formula : C23H32D4N2O4

  • Molecular Weight : 408.58

Drug Reference Standards & Impurity Synthesis in India
PA 05 92510

(1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-((2-((2-hydroxy-1-phenylethyl)amino)ethyl)amino)-3-(pyrrolidin-1-yl)propan-1-ol

(1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-((2-((2-hydroxy-1-phenylethyl)amino)ethyl)amino)-3-(pyrrolidin-1-yl)propan-1-ol


  • Catalogue No.:PA 05 92510

  • CAS :

    NA

  • Molecular Formula : C25H35N3O4

  • Molecular Weight : 441.57

Drug Reference Standards & Impurity Synthesis in India
PA 05 92520

(S)-(2-Hydroxy-1-phenylethyl)glycine

(S)-(2-Hydroxy-1-phenylethyl)glycine


  • Catalogue No.:PA 05 92520

  • CAS :

    924012-02-2

  • Molecular Formula : C10H13NO3

  • Molecular Weight : 195.22

Drug Reference Standards & Impurity Synthesis in India
PA 05 92530

N-(3-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-oxoprop-1-en-2-yl)octanamide

N-(3-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-oxoprop-1-en-2-yl)octanamide


  • Catalogue No.:PA 05 92530

  • CAS :

    2514773-76-1

  • Molecular Formula : C19H25NO4

  • Molecular Weight : 331.41

Drug Reference Standards & Impurity Synthesis in India
PA 05 92540

N-[(1R,2S)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]-octanamide

N-[(1R,2S)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]-octanamide


  • Catalogue No.:PA 05 92540

  • CAS :

    1092472-66-6

  • Molecular Formula : C23H36N2O4

  • Molecular Weight : 404.55

Drug Reference Standards & Impurity Synthesis in India
PA 05 92550

N-[(1S,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide

N-[(1S,2R)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide


  • Catalogue No.:PA 05 92550

  • CAS :

    1092472-65-5

  • Molecular Formula : C23H36N2O4

  • Molecular Weight : 404.55

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921000

1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-(pyrrolidin-1-yl)propan-2-one

1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-(pyrrolidin-1-yl)propan-2-one


  • Catalogue No.:PA 05 0921000

  • CAS :

    NA

  • Molecular Formula : C15H19NO3

  • Molecular Weight : 261.32

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921001

(2S,3R)-2-Amino-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-hydroxy-1-(pyrrolidin-1-yl)propan-1-one

(2S,3R)-2-Amino-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-hydroxy-1-(pyrrolidin-1-yl)propan-1-one


  • Catalogue No.:PA 05 0921001

  • CAS :

    NA

  • Molecular Formula : C15H20N2O4

  • Molecular Weight : 292.34

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921002

(R)-4-((2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)methyl)-5-phenylmorpholin-2-one

(R)-4-((2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)methyl)-5-phenylmorpholin-2-one


  • Catalogue No.:PA 05 0921002

  • CAS :

    NA

  • Molecular Formula : C19H19NO4

  • Molecular Weight : 325.36

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921003

(1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-(((S)-2-hydroxy-1-phenylethyl)amino)propane-1,3-diol

(1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-(((S)-2-hydroxy-1-phenylethyl)amino)propane-1,3-diol


  • Catalogue No.:PA 05 0921003

  • CAS :

    NA

  • Molecular Formula : C19H23NO5

  • Molecular Weight : 345.4

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921004

N-((1S,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)hexanamide

N-((1S,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)hexanamide


  • Catalogue No.:PA 05 0921004

  • CAS :

    NA

  • Molecular Formula : C21H32N2O4

  • Molecular Weight : 376.5

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921005

N-((1S,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)heptanamide

N-((1S,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)heptanamide


  • Catalogue No.:PA 05 0921005

  • CAS :

    NA

  • Molecular Formula : C22H34N2O4

  • Molecular Weight : 390.52

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921006

N-((1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-oxo-3-(pyrrolidin-1-yl)propan-2-yl)nonanamide

N-((1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-oxo-3-(pyrrolidin-1-yl)propan-2-yl)nonanamide


  • Catalogue No.:PA 05 0921006

  • CAS :

    NA

  • Molecular Formula : C24H36N2O5

  • Molecular Weight : 432.56

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921007

1-((2R,3R)-3-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-hydroxy-2-nonanamidopropyl)pyrrolidine 1-Oxide

1-((2R,3R)-3-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-3-hydroxy-2-nonanamidopropyl)pyrrolidine 1-Oxide


  • Catalogue No.:PA 05 0921007

  • CAS :

    NA

  • Molecular Formula : C24H38N2O5

  • Molecular Weight : 434.58

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921008

N-((2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)nonanamide

N-((2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)nonanamide


  • Catalogue No.:PA 05 0921008

  • CAS :

    NA

  • Molecular Formula : C24H38N2O4

  • Molecular Weight : 418.58

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921009

N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide

N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)-2,3-dihydrobenzo[b][1,4]dioxine-6-carboxamide


  • Catalogue No.:PA 05 0921009

  • CAS :

    NA

  • Molecular Formula : C24H28N2O6

  • Molecular Weight : 440.5

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921010

(1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-nonanamido-3-(pyrrolidin-1-yl)propyl Octanoate

(1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-2-nonanamido-3-(pyrrolidin-1-yl)propyl Octanoate


  • Catalogue No.:PA 05 0921010

  • CAS :

    NA

  • Molecular Formula : C32H52N2O5

  • Molecular Weight : 544.78

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921011

Eliglustat enantiomer

N-[(1S,2S)-2-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2-hydroxy-1-(1-pyrrolidinylmethyl)ethyl]octanamide


  • Catalogue No.:PA 05 0921011

  • CAS :

    1092472-70-2

  • Molecular Formula : C23H36N2O4

  • Molecular Weight : 404.55

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921012

Eliglustat Acetamide Amino Alcohol

Eliglustat Acetamide Amino Alcohol


  • Catalogue No.:PA 05 0921012

  • CAS :

    491833-26-2

  • Molecular Formula : C23H28N2O5

  • Molecular Weight : 412.49

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921013

Eliglustat Amide Amino Alcohol

Eliglustat Amide Amino Alcohol


  • Catalogue No.:PA 05 0921013

  • CAS :

    686710-19-0

  • Molecular Formula : C15H20N2O4

  • Molecular Weight : 292.34

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921014

N-Nitroso Eliglustat

N-Nitroso Eliglustat


  • Catalogue No.:PA 05 0921014

  • CAS :

    NA

  • Molecular Formula : C23H35N3O5

  • Molecular Weight : 433.55

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921015

N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)-7-hydroxyoctanamide

N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)-7-hydroxyoctanamide


  • Catalogue No.:PA 05 0921015

  • CAS :

    NA

  • Molecular Formula : C23H36N2O5

  • Molecular Weight : 420.55

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921016

N-((1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-oxo-3-(pyrrolidin-1-yl)propan-2-yl)octanamide

N-((1R,2S)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-oxo-3-(pyrrolidin-1-yl)propan-2-yl)octanamide


  • Catalogue No.:PA 05 0921016

  • CAS :

    2313482-21-0

  • Molecular Formula : C23H34N2O5

  • Molecular Weight : 418.53

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921017

Eliglustat Racemic Mixture

Eliglustat Racemic Mixture


  • Catalogue No.:PA 05 0921017

  • CAS :

    886359-89-3

  • Molecular Formula : C23H36N2O4

  • Molecular Weight : 404.55

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921018

Eliglustat Enantiomer Tartrate Salt

Eliglustat Enantiomer Tartrate Salt


  • Catalogue No.:PA 05 0921018

  • CAS :

    1092472-71-3

  • Molecular Formula : C27H42N2O10

  • Molecular Weight : 554.64

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921019

N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(nitroso(4-oxobutyl)amino)propan-2-yl)octanamide

N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(nitroso(4-oxobutyl)amino)propan-2-yl)octanamide


  • Catalogue No.:PA 05 0921019

  • CAS :

    NA

  • Molecular Formula : C23H35N3O6

  • Molecular Weight : 449.55

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921020

N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)-N-(2-((2-hydroxy-1-phenylethyl)amino)ethyl)nitrous amide

N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)-N-(2-((2-hydroxy-1-phenylethyl)amino)ethyl)nitrous amide


  • Catalogue No.:PA 05 0921020

  • CAS :

    NA

  • Molecular Formula : C25H34N4O5

  • Molecular Weight : 470.57

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921021

N-(2-(((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)amino)ethyl)-N-(2-hydroxy-1-phenylethyl)nitrous amide

N-(2-(((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)amino)ethyl)-N-(2-hydroxy-1-phenylethyl)nitrous amide


  • Catalogue No.:PA 05 0921021

  • CAS :

    NA

  • Molecular Formula : C25H34N4O5

  • Molecular Weight : 470.57

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921022

N-(2-(((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)(nitroso)amino)ethyl)-N-(2-hydroxy-1-phenylethyl)nitrous amide

N-(2-(((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)(nitroso)amino)ethyl)-N-(2-hydroxy-1-phenylethyl)nitrous amide


  • Catalogue No.:PA 05 0921022

  • CAS :

    NA

  • Molecular Formula : C25H33N5O6

  • Molecular Weight : 499.57

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921023

Eliglustat N-oxide

Eliglustat N-oxide


  • Catalogue No.:PA 05 0921023

  • CAS :

    2137145-62-9

  • Molecular Formula : C23H36N2O5

  • Molecular Weight : 420.55

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921024

N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)decanamide

N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)decanamide


  • Catalogue No.:PA 05 0921024

  • CAS :

    491833-31-9

  • Molecular Formula : C25H40N2O4

  • Molecular Weight : 432.61

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921025

Eliglustat Phenyl Amino Alcohol Impurity

Eliglustat Phenyl Amino Alcohol Impurity


  • Catalogue No.:PA 05 0921025

  • CAS :

    491833-27-3

  • Molecular Formula : C23H30N2O4

  • Molecular Weight : 398.5

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921026

Eliglustat Hexa Analogue

Eliglustat Hexa Analogue


  • Catalogue No.:PA 05 0921026

  • CAS :

    2193051-88-4

  • Molecular Formula : C21H32N2O4

  • Molecular Weight : 376.5

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921027

N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)nonanamide

N-((1R,2R)-1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)nonanamide


  • Catalogue No.:PA 05 0921027

  • CAS :

    491833-30-8

  • Molecular Formula : C24H38N2O4

  • Molecular Weight : 418.58

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921028

Eliglustat O-octonyl Dimer

Eliglustat O-octonyl Dimer


  • Catalogue No.:PA 05 0921028

  • CAS :

    2193052-06-9

  • Molecular Formula : C31H50N2O5

  • Molecular Weight : 530.75

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921029

(1R,2R)-2-Amino-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(pyrrolidin-1-yl)propan-1-ol

(1R,2R)-2-Amino-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(pyrrolidin-1-yl)propan-1-ol


  • Catalogue No.:PA 05 0921029

  • CAS :

    491833-28-4

  • Molecular Formula : C15H22N2O3

  • Molecular Weight : 278.35

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921030

(2S,3R)-2-(Dibenzylamino)-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-hydroxy-1-(pyrrolidin-1-yl)propan-1-one

(2S,3R)-2-(Dibenzylamino)-3-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-hydroxy-1-(pyrrolidin-1-yl)propan-1-one


  • Catalogue No.:PA 05 0921030

  • CAS :

    2342605-11-0

  • Molecular Formula : C29H32N2O4

  • Molecular Weight : 472.59

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921031

2,5-Dioxopyrrolidin-1-yl octanoate

2,5-Dioxopyrrolidin-1-yl octanoate


  • Catalogue No.:PA 05 0921031

  • CAS :

    14464-30-3

  • Molecular Formula : C12H19NO4

  • Molecular Weight : 241.29

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921032

2-Amino-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(pyrrolidin-1-yl)propan-1-ol

2-Amino-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-3-(pyrrolidin-1-yl)propan-1-ol


  • Catalogue No.:PA 05 0921032

  • CAS :

    2313482-41-4

  • Molecular Formula : C15H22N2O3

  • Molecular Weight : 278.35

Drug Reference Standards & Impurity Synthesis in India
PA 05 0921033

N-(1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)acetamide

N-(1-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)-1-hydroxy-3-(pyrrolidin-1-yl)propan-2-yl)acetamide


  • Catalogue No.:PA 05 0921033

  • CAS :

    NA

  • Molecular Formula : C17H24N2O4

  • Molecular Weight : 320.39

pharmaffiliates